News | News By Subject | News by Disease News By Date | Search News

Endometrial Cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News

News from Around the Web
Black Women With Fibroids Face Elevated Risk Of Endometrial Cancer, Boston University Study     3/30/2016
Drinking Coffee May Lower Endometrial Cancer Risk, Imperial College London Study     2/9/2015
No Proof That Soy Food Protects Against Cancer, National Cancer Center Study     6/20/2014
Diabetes Treatment May Also Provide Protection Against Endometrial Cancer, University of Warwick and Warwick Medical School Study     4/6/2011
'Sandwich' Tx Helps in Rare Endometrial Cancer, Montefiore Medical Center Study     3/9/2011
How Dietary Supplement May Block Cancer Cells, Ohio State University Study     7/1/2010
New Chemotherapy Combination Shows Promise in Endometrial Cancer, University of Texas MD Anderson Cancer Center Researchers Find     3/19/2010
Single Gene Mutation Induces Endometrial Cancer, UT Southwestern Medical Center Study     2/12/2010
Potent Suppressor Of Endometrial Cancer Is Revealed, University of Texas Southwestern Medical Center and Harvard Medical School Study     2/8/2010
Gene Mutation Marks Aggressive Endometrial Cancer, Washington University School of Medicine Study     5/28/2009
Contraceptives Protect Against Endometrial Cancer     11/22/2006
Two Types Of HRT Raise Risk Of Womb Cancer     4/29/2005
Study Confirms Tamoxifen Raises Endometrial Cancer Risk     3/2/2005
Tamoxifen's Side Effects Scare Away Some     12/15/2004
Animal Research Suggests That Stress May Increase Risk Of Uterine Cancer     7/12/2004

Press Releases
Xenetic Biosciences Announces FDA Acceptance Of Investigational New Drug Application To Initiate Phase II Clinical Trial Of Virexxa In Endometrial Cancer     8/19/2016
ASCO2016: AEterna Zentaris (AEZS) Reconfirms Commitment To LHRH-Receptor Targeting Zoptrex During 2016 ASCO Annual Meeting     6/7/2016
Myriad Genetics (MYGN) Release: The Myriad Myrisk Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations In Patients With Endometrial Cancer     3/18/2016
PapGene, Inc. Awarded Grant For Test To Detect Ovarian And Endometrial Cancers     2/4/2016
AEterna Zentaris (AEZS) To Participate In 18th Annual BIO CEO & Investor Conference Seeking Partnering Opportunities     2/2/2016
ArQule, Inc. (ARQL) To Present Data On Tivantinib, ARQ 087, ARQ 092, And ARQ 751 At AACR-NCI-EORTC Conference     10/27/2015
AEterna Zentaris (AEZS): Data And Safety Monitoring Board Recommends Continuation Of ZoptEC Phase 3 Trial In Advanced Endometrial Cancer     10/13/2015
Galena Biopharma  (GALE) Presents Positive GALE-301 Phase 2a Clinical Trial Data At The European Cancer Congress 2015     9/28/2015
Galena Biopharma  (GALE) To Present GALE-301 Phase 2a Clinical Trial Data At The European Society For Medical Oncology (ESMO)     9/14/2015
Esperance Pharmaceuticals, Inc. Announces Strategic Alliance With MD Anderson Cancer Center     8/24/2015
AEterna Zentaris (AEZS) Second Quarter Financial And Operating Results     8/14/2015
AEterna Zentaris (AEZS) Announces Data And Safety Monitoring Board Scheduled To Complete Second Interim Analysis Of The ZoptEC Phase 3 Trial In Endometrial Cancer In Early October     8/11/2015
AEterna Zentaris (AEZS) And Sinopharm A-Think Sign Master Collaboration Agreement For Zoptarelin Doxorubicin In China     12/1/2014
AEterna Zentaris (AEZS) Adds Hollings Cancer Center To Multi-National Phase 3 Trial In Endometrial Cancer     11/20/2014
Galena Biopharma  (GALE) Completes Enrollment In GALE-301 Phase 2a Clinical Trial In Ovarian And Endometrial Cancers     6/17/2014

//-->